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Introduction
Escherichia coli is present in the normal microflora of the
intestinal tract of chickens. However, some of these E. coli
strains are able to cause disease under certain conditions,
like abnormal predominance over the other gut flora,
host depressed immune system or adverse environmental
exposure. Extra-intestinal pathogenic E. coli, termed avian
pathogenic E. coli (APEC) possess specific virulence attri-
butes causing invasive infections in poultry (chickens and
turkeys), namely colibacillosis (Zhao et al. 2005). The
pathogenesis of APEC infections include the colonization
of the respiratory tract, the crossing of the epithelium
and penetration into the mucosa of the respiratory
organs, the survival and multiplication in the blood
stream and in the internal organs, and the production of
adverse effects and lesions in cells and tissues (Dho-Mou-
lin and Fairbrother 1999). These bacteria can be typed
according to the somatic cell-wall antigen (O-antigen), or
the flagella antigen (H-antigen). In poultry, 10–15% of
the serotypes are pathogenic, and are present in the poul-
try environment causing a variety of disease syndromes
including colibacillosis (Barnes and Gross 1997).
Avian colibacillosis is a complex syndrome character-
ized by multiple organ lesions, typically pericarditis,
airsacculitis, perihepatitis and peritonitis, and in its acute
form degenerates in septicaemia. The consequent chick-
ens’ high mortality rates and carcass rejection at slaugh-
ter causes significant economic losses in the poultry
industry worldwide (Delicato et al. 2003; Ewers et al.
2004). The most important source of transmission seems
to be faecal contamination through the inhalation of the
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Abstract
Aims: To isolate and characterize bacteriophages, and to evaluate its lytic per-
formance against avian pathogenic Escherichia coli (APEC) strains with high
patterns of antibiotic resistance, in order to select phages for a therapeutic
product to treat colibacillosis in chickens.
Methods and Results: Bacteriophages were isolated from poultry sewage and
tested against 148 O-serotyped APEC strains. The morphological characteriza-
tion of the bacteriophages was made by transmission electronic microscopy
(TEM) observations and the genetic comparison between bacteriophages DNA
was performed by restriction fragment length polymorphism (RFLP) patterns.
Results showed that 70Æ5% of the tested E. coli strains were sensitive to a
combination of three of the five isolated phages, that seemed to be virulent
and taxonomically belong to the Caudovirales order. Two of them look like
16–19, T4-like phages (Myoviridae) and the third is a T1-like phage and
belongs to Syphoviridae family. All of them are genetically different.
Conclusions: It was possible to obtain a combination of three different lytic
bacteriophages with broad lytic spectra against the most prevalent O-serotypes
of APEC.
Significance and Impact of the Study: Data reported in this study, presents an
in vitro well studied phage product to be used as antimicrobial agent to treat
colibacillosis in poultry industry.
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microrganism into the respiratory tract (Barnes and
Gross 1997).
Escherichia coli isolates from poultry are frequently
resistant to multiple drugs (Levy 2001, 2002). An
increased concern over the consequences of the mecha-
nisms that bacteria have developed, to prevent the inhibi-
tory effects of the antibiotics in the treatment of animal
bacterial infections is widespread (Schwarz and Chaslus-
Dancla 2001; Huff et al. 2004). The antibiotic capacity to
select and allow proliferation of resistant bacteria is an
important clinical problem with public health conse-
quences. Antibiotic residues can be found in the environ-
ment for long periods of time after treatment (Levy
2002). These active ingredients affect the microbial
community as long as they remain intact and at growth
inhibitory levels (Levy 2001).
World Health and Life Science institutions are con-
cerned about a range of deleterious effects that antimicro-
bial resistant bacteria may have on human health, like
increased duration of illness, treatment failure, and loss of
therapeutic options as a consequence of human exposure
to resistant bacteria through ingestion of animal derived
food products. There have been three comprehensive
reviews and reports on the problem of bacterial antibiotic
resistance, each of which comments on the use and abuse
of antimicrobials in food animal production, and recom-
mends application of alternative methods of reducing
microbial pathogens loads (FDA 2000a; WHO 2001;
Isaacson and Torrence 2002). Also in animal production,
there is serious consideration being given to restrictions
on the use of antibiotics (FDA 2000b).
Phage therapy is presented as an alternative to antimi-
crobial therapies. Bacteriophages or phages are viruses
that exclusively infect bacterial cells. If they are obligate
lytic phages, or virulent phages, multiply in the host
bacteria and lyse it at the end of the cycle, after immedi-
ate replication of new phage particles. As soon as the cell
is destroyed, the new phages can find new hosts. Like all
viruses, phages are metabolically inert in their extra cellu-
lar form. These structures are only able to self-reproduce
as long as the host bacteria is present, and thus are not
toxic to non specific bacteria, animals or plants. In fact,
their replication depends exclusively on the infection of a
specific bacterial host and on the utilization of the host
intracellular machinery to translate their own genetic
code. Phages are part of both gastrointestinal and envi-
ronmental ecosystems and are among the simplest and
most abundant organisms on earth (Carlton 1999; Sula-
kvelidze et al. 2001). Lytic phages are suitable for phage
therapy in opposition to temperate phages. The former
do not include the integrase genes on their genome, they
lack the molecular basis for coexistence with the host and
the potentiality to carry harmful genes from one host to
another (Karam 1994; Brussow 2005; Skurnik and Strauch
2006).
Recently, well-controlled animal models have demon-
strated that phages can rescue animals (chickens, mice,
calves, pigs, lambs, fishes, etc.) from a variety of harmful
infections, like E. coli or Salmonella infections (Smith and
Huggins 1982, 1983; Smith et al. 1987; Berchieri et al.
1991; Barrow et al. 1998; Park et al. 2000; Sklar and Joer-
ger 2001; Huff et al. 2002; Bru Ronda et al. 2003; Huff
et al. 2003).
In this study, in vitro efficiency of five phages was eva-
luated based on lytic spectra against 148 avian pathogenic
E. coli (APEC) strains. The best lytic performance was
obtained with a combination of tree phages. In order to
characterize these phages, an effective phage sorting
scheme based on phage life cycle, lytic efficiency rate,
morphology and on phage DNA restriction endonuclease
digestion profile (RFLP) was conducted.
Materials and methods
Escherichia coli isolation
Escherichia coli strains were isolated from organs (liver,
spleen, lungs) of infected commercial birds, with typical
lesions of colibacillosis. Organs were emulsified in sterile
saline solution 0Æ85% NaCl (Sigma, Osterode am Harz,
Germany) and 0Æ1 ml of supernatant was plated in
MacConkey agar (Biokar Diagnostics, Pantin Cedex,
France), a selective medium for Gram-negative bacilli,
which differentiates lactose fermenters (pink-red colonies)
from nonfermenters bacteria. As approximately 95% of
E. coli ferment lactose (Murray et al. 1991), pink red
colonies were collected from plates and the specie confir-
mation of the isolates was conducted by using API strips
according to manufacturer’s instructions (Bio-Merieux,
Marcy l’Etoile, France). Escherichia coli isolates were
stored in Nutrient Broth (Oxoid, Hampshire, UK) with
20% glycerol at )80C.
Escherichia coli serotyping for the O-antigen
The O-antigen serotyping of E. coli strains was performed
using a ‘kit for serotyping avian septicemic E. coli strains’,
supplied by the ‘Laboratorio de Referencia de E. coli
(LREC)’ of the Veterinary Faculty of Lugo, Spain. The kit
included 26 antisera: O1, O2, O5, O6, O8, O9, O11, O12,
O14, O15, O17, O18, O20, O35, O36, O45, O53, O78,
O81, O83, O88, O102, O103, O115, O116 and O132. If
the strain was negative for all these antisera, it was
considered not typeable (N ⁄T) with this kit. Samples were
prepared and procedures were carried out according to
the supplied protocol.
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Antibiotic susceptibility testing of APEC
The isolated APEC strains were subjected to antibiotic
susceptibility testing. The active ingredients with systemic
action (relayed throughout the blood circulation) in poul-
try, generally used for colibacillosis treatment were selected
to perform this antimicrobial test. In order to label strains
as susceptible, intermediate or resistant, antibiotic discrimi-
nating concentrations were used: ampicillin (AMP),
10 lg disc)1, doxycycline (DO), 30 lg disc)1, enrofloxacin
(ENR), 5 lg disc)1, sulphamethoxazole ⁄ trimethropim
(STX), 25 lg disc)1, nalidixic acid (NA), 30 lg disc)1,
pipemidic acid (PIP), 20 lg disc)1, tetracycline (TE),
10 lg disc)1, oxolinic acid (OA), 2 lg disc)1 and amoxy-
cillin (AML), 30 lg disc)1 (Oxoid).
Each strain was plated in Mueller Hinton agar (Biokar
Diagnostics), and the discs with the antibiotics were
placed over the bacteria layer (Bauer et al. 1966). Plates
were incubated at 37C overnight. After this period, the
diameter of the clear zone was measured and strains
classified according to the sensitivity to each antibiotic.
An E. coli reference control culture (ATCC 25922) was
used for quality control of the test.
Bacteriophage isolation and purification
Bacteriophages were isolated from samples of poultry
sewage, collected randomly from Portuguese poultry
houses. Under sterile conditions samples were emulsified
in Luria Bertani (LB) broth (Sigma), and the decanted
supernatant obtained from each emulsion was added to
an early-log grown mixture of eight E. coli strains selected
randomly, from different O-antigene serotypes. Suspen-
sions were incubated overnight at 37C, with shaking
(120 rev min)1) and were then centrifuged at 9000 g for
10 min (rotor 19776, Sigma 3–16k). The supernatant was
then filtered through a 0Æ22 lm membrane, 33 mm Mil-
lex Filter Units, Durapore (PVDF) (Millipore, Bedford,
MA, USA). The spot test method was used as an initial
test for the presence of phage. A procedure based on the
double layer plaque technique was performed (Carey-
Smith et al. 2006). Layers of 3 ml of LB 0Æ6% agar
(Sigma), previously inoculated with 100 ll of each E. coli
strain used above, 6–8 h culture were spotted with 10 ll
of the filtered suspension. This procedure was performed
over LB 1Æ5% agar. Plates were incubated at 37C over-
night. A clear zone in the plate, resulting from the lysis of
host bacterial cells, indicated the presence of phage.
In order to isolate phages from this clear lysis zone,
serial dilutions in phage buffer (100 mmol l)1 NaCl
(Sigma), 8 mmol l)1 MgSO4 (Sigma), 50 mmol l
)1 Tris
(Sigma), pH 7Æ5) were done from the phage stocks
obtained above. A colony of the respective hosts strains
were grown 3–4 h (early-log phase culture) in 5 ml of LB
broth. A volume of 100 ll of phage-containing sample
and 100 ll of host culture were mixed with 3 ml of 0Æ6%
LB agar, overlaid onto 1Æ5% LB agar plates and incubated
overnight at 37C. Phages were purified by successive
single plaque isolation, from the higher dilutions plates
where plaques were still distinct. A single plaque was picked
from the bacteria lawn, inoculated into an early-log phase
host culture, and the lysate plated as described above. After
repeating the cycle three more times, lysates from single
plaques were treated with chloroform 4 : 1 (v ⁄ v), mixed
and centrifuged at 5000 g for 5 min. The phages were
recovered from the upper phase suspension and filtered
trough 0Æ22 lm. Phages stocks were stored at 4C.
Phage lytic spectra of the typed E. coli strains
Bacterial susceptibility to bacteriophage was assayed for the
148 isolated E. coli strains by adapting a modified proce-
dure of the traditional double-layer technique (Carey-
Smith et al. 2006). Once the top agar was solidified at room
temperature, 10 ll of the phage lysate suspension of about
107 PFU ml)1 was spotted, incubated at 37C overnight
and examined for the presence of a clear zone of lysis.
Bacteriophage amplification
The amplification of each isolated bacteriophage was per-
formed by inoculating 5 ml of the purified phage suspen-
sions in 10 ml of a 3–4 h culture (in LB broth) of the
respective E. coli hosts. It was incubated overnight at
37C, with shaking (120 rev min)1). The suspension was
centrifuged at 9000 g for 10 min and filtered trough a
0Æ22 lm membrane. This procedure was repeated again,
by inoculating the resulting phage lysate volume in 100 ml
of 3–4 h culture followed by incubation overnight at 120
rev min)1 and 37C. The resultant phage suspension was
filtered through a 0Æ22 lm membrane and stored at 4C.
The number of phages present in this suspension was
determined according to the Adams (Adams 1959) method
with minor modifications. Successive dilutions of the
phage suspension were performed in a saline solution
(0Æ85% NaCl) and 100 ll of each dilution together with
100 ll of the respective bacterial host suspension were
mixed with 3 ml of LB 0Æ6% top agar layer and placed over
a 1Æ5% LB agar bottom layer. Plates were incubated over-
night at 37C. Phage titration was performed in triplicate.
Phages life cycle investigation by the induction of
infected host strains with mitomycin C
In order to evaluate if phages selected based on the lysis
efficiency were able to insert their genome in bacteria
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DNA remaining as a prophage, some tests were per-
formed. Lambda (k) phage (DSM 4499), a Siphoviridae
temperate phage, and the respective E. coli host (DSM
4230) were used as positive controls. Reconstitution,
propagation and storage of this phage and E. coli host
strain were conducted according to the supplier instruc-
tions (DSMZ, Braunschweig, Germany).
Each of the host strains were early-log grown in LB
broth and 20 ll of the respective phage were spotted on
the lawns, as described above. After an overnight incuba-
tion at 37C, bacteria colonies change in the central lytic
zone (resistant colonies) were picked (at least five colonies)
and purified by successive sub-culturing in MacConkey
agar, to remove attached phage particles. Phage resistance
of those isolated strains was confirmed by the cross-streak-
ing test and the spot lysis assay, and those phage resistant
colonies were stress induced with mitomycin C (Sigma).
The strains were grown in 200 ml of LB until an optical
density at 600 nm of 0Æ2 was reached. The induction of
phage release was attempted via overnight incubation at
37C, in the presence of mitomycin C (1 lg ml)1). A neg-
ative control, without mitomycin C was prepared. Bacteria
lysate was centrifuged at 9000 g. The supernatant was
filtered through 0Æ22 lm and tested against each phage-
sensitive host strain [wild-type (WT)] (Keel et al. 2002;
Harel et al. 2003). After an overnight incubation at 37C,
bacterial lawns were checked for clear zones.
Electron microscopy
Phage particles were sedimented at 25 000 g for 60 min
using a Beckman (Palo Alto, CA) J2-21 centrifuge with a
JA 18Æ1 fixed-angle rotor. Phages were washed twice in
0Æ1 mol l)1 ammonium acetate, pH 7Æ0 (Sigma), depos-
ited on copper grids (Ernest F. Fullam, Clifton Park, NY,
USA) provided with carbon-coated Formvar films (Cane-
mco & Marivac, Quebec, Canada), stained with 2%
potassium phosphotungstate, pH 7Æ2 (Sigma) and exam-
ined in a Philips (Eindhoven, the Netherlands) EM 300
transmission electron microscope (TEM), operating
60 kV. Magnification was monitored with catalase crystals
(performed by Dr H.W. Ackermann, Laval University,
Quebec, Canada).
Phage purification by CsCl precipitation
An ultracentrifugation method was performed based on a
caesium chloride density gradient. Four different solutions
were prepared in phage buffer: 1Æ70, 1Æ50 and 1Æ30 g ml)1
CsCl (Sigma). After the volume of each phage suspension
was measured, 0Æ5 g ml)1 of CsCl was added. These sus-
pensions were ultracentrifuged (XL-90, Beckman) at 60
000 g for 2 h at 4C. A bluish band indicative of phage
particles was collected and placed in a microtube (Sam-
brook and Russell 2001). A Centricon 20 spin filter unit
(millipore) was used to reduce the volume of the recov-
ered CsCl purified phage concentrate. The centrifugation
was performed at 4000 g for 10 min at 4C. The phage
concentrate was then washed with the phage buffer 1 : 4
(v ⁄ v) and centrifuged with the same settings in the filtra-
tion module, three more times, to remove all the CsCl.
The resulted suspension was stored at 4C.
RFLP pattern analysis
Differences between phages were confirmed by compari-
son between the individual restriction fragment length
polymorphism (RFLP) patterns. A volume of 200 ll of
the concentrated phage suspension by CsCl precipitation,
was preincubated 30 min at 37C with 1 ll of RNase
20 mg ml)1 (Sigma) and submitted to DNA purification
according to the protocol provided with a commercial
kit, High Pure PCR Template Preparation Kit (Roche,
Mannheim, Germany). Uncut phage DNA was run at
90 V for 45 min, in a 0Æ8% agarose gel (Qbiogene, Irvine,
CA, USA) stained with ethidium bromide (Bio-Rad, Her-
cules, CA), to verify extraction yield and absence of bacte-
rial genomic DNA. XapI, BseGI and SchI restriction
enzymes (Fermentas, St Leon-Rot, Germany) were used
in order to obtain phage DNA RFLP patterns. A concen-
tration of 5 U ll)1 of each enzyme and the respective
enzyme buffers 1 · diluted in RNase and DNase free
water (Biological Industries, M.P. Ashrat, Israel) were
added to 6 ll of phage DNA, with a final volume of the
reaction mixture of 30 ll. Tubes were incubated at 37C
for 3 h, according to supplier instructions. The loading
buffer used to improve resolution was 1 · DNA Loading
Dye & SDS Solution (Fermentas) and was added to the
samples at 1 : 6 (v ⁄ v). Tubes were incubated at 65C for
10 min and chilled on ice. Samples were loaded in a 1 cm
thick, 2Æ0% agarose gel stained with ethidium bromide.
Electrophoresis was carried out at 45 V for 5 h in a
dark place.
Results
APEC O-serogroup and antibiotics susceptibility
The most common O-serotype of the 148 isolated APEC
strains was the O78 with a frequency of 40Æ5%, followed
by O2, O5 and O88 representing from 5Æ2% to 6Æ9% of
the isolated bacteria. It was not possible with the kit used
to type 34Æ7% of the bacterial strains. Escherichia coli sero-
types as O1, O8, O99, O15, O20, O53, O86 and O103
were present at a low frequency (from 0Æ6% to 1Æ7%),
while O6, O9, O12, O14, O17, O18, O35, O36, O45, O81,
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O83, O102, O115, O116 and O132 were not detected
(Fig. 1).
Escherichia coli strains were also grouped according to
the respective O-serotype, by strain of birds, age or
species, according to the source of isolation. Figure 2
refers to the relative distribution of O-serotypes per group
of birds. It is possible to verify that different O-serotypes
infected the same group of birds. For example, serotypes
like O1, O2, O78 and N ⁄T were isolated from laying
hens, O8, O15, O78, O86, O88, O103 and N ⁄T were iso-
lated from broilers, O1, O2, O5, O11, O53, O78, O88,
O103 and N ⁄T from label chickens, O2, O5, O20, O78,
O88 and N ⁄T were found in chicks, O78 and N ⁄T in
breeders and O2, O5, O78 and N ⁄T were isolated from
turkeys. It was observed that the isolated O-typeable
strain more frequent in all the groups, was the O78.
The isolated strains were then subjected to an antibiotic
sensitivity test and the percentages of susceptible, inter-
mediate or resistant strains to each antibiotic are present
in Fig. 3.
It was observed that 80–90% of the strains were resis-
tant to TE, DO, OA and NA, 70–75% were resistant to
AMP and PIP, 66Æ5% to AML, 61Æ6% to STX and 47Æ5%
to ENR. The active ingredient with higher effectiveness to
this group of strains was ENR, active against 50Æ8% of the
APEC.
The bacteriophage lysis efficiency
Five phages were isolated: phiF78E, phiF258E, phiF2589E,
phiF61E and phiF5318E. Phage lysis efficiency for the 148
O-serotyped strains is illustrated in Tables 1 and 2. From
Table 1, it is apparent that all the phages were effective
against O78, O5 and N ⁄T E. coli strains and most of
them were active for O2 and O88. From the low
N/T
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45Figure 1 Relative frequency (%) of the APEC
O-serotypes.
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Figure 2 Relative frequency (%) of E.coli main isolated serotypes,
according to the birds’ strain, specie or age. O-serotypes described as
‘others’ are O8, O11, O15, O20, 053, 086 and O103, and were
found in bacteria collected from broilers, 2Æ9% O8, 2Æ9% O15, 2Æ9%
O86 and 2Æ9% O103, label chickens, 1Æ4% O11, 1Æ4% O53 and
2Æ8% O103 and chicks (5Æ6% O20). ( , O1; , O2; , O5; , O78;
, O 88; , NT; , Others).
100%
80%
60%
40%
20%
0%
ENR TE DO STX AMP NA PIP AO AML
Figure 3 Relative comparison (%) of the isolated strains according to
susceptibility, intermediate susceptibility or resistance to a range of
antibiotics commonly used for therapy in poultry industry. AMP,
ampicillin; DO, doxycycline; ENR, enrofloxacin; STX, sulphameth-
oxazole ⁄ trimethropim; NA, nalidixic acid; PIP, pipemidic acid; TE,
tetracycline; OA, oxolinic acid; AML, amoxycillin. ( , susceptible;
, intermediate; , resistant).
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frequency O-typed strains (Fig. 1), O1, O20 and O53
were not sensitive to any of the tested phages.
Generally, observing the host lysis performance of
each phage (Table 2), phiF258E and phiF61E were found
to have the broadest host range, 44Æ6% and 48Æ0%,
respectively.
Figure 4 illustrates the best phage association according
to the higher percentage of lysed strains, in groups of two,
three, four and five phages. When combining them in
groups of two, the strongest lysis association was between
phiF78E and phiF61E (60Æ4%). Groups of three phages,
phiF78E, phiF258E and phiF61E, presented a higher lysis
percentage, 70Æ5%. Associations of four and five phages are
able to lyse, respectively 71Æ8% and 72Æ5% and thus does
not bring a relevant advantage for lytic spectra range when
compared with an association of three phages. Based on
these results, the phages selected for further characteriza-
tion were phiF78E, phiF258E and phiF61E.
Characterization of phages phiF78E, phiF258E and
phiF61E
Phages phiF258E and phiF61E formed very clear lytic
zones on their hosts (H816E and H161E, respectively)
exhibiting no resistant bacteria. Conversely, phiF78E
induced the formation of resistant colonies on H561E
lawns after subculture, which may be an indication of
lysogeny. Temperate phages integrate into the DNA hosts
and only lyse the cells under certain conditions. Stress
induced infected cells with temperate phages usually
results in the release of the phage. So, the mitomycin C
assay with the phiF78E resistant bacterial cells was per-
formed. Infected E. coli DSM 4230 with k bacteriophage
was used as a positive control. In the assay no clear zone
was found after stress inducing phiF78E resistant bacteria,
which indicated that phiF78E is not temperate.
Electron micrographs demonstrated that all phages do
not possess any lipidic envelope. Phages phiF78E and
phiF61E had a neck with a tiny collar and a contractile
tail. phiF78E has caudal fibres (20 · 2 nm) (Fig. 5a).
phiF78E and phiF61E capsids were 103 · 42 nm and the
tails 100 · 17 nm (Fig. 5a,c, respectively). phiF258E has a
circular head with diameter of 62 nm and is characterized
by a flexible tail of 160 · 8 nm (Fig. 5b).
It was possible to observe discriminatory bands in each
phage DNA restriction pattern for a given enzyme (Fig. 6).
For example the digestion of the phiF78E DNA with BseGI
showed a distinct band between 2300 and 2000 bp, while
F258E DNA digested with the same enzyme exhibited a
strong band above 23 000 bp and others of lower molecu-
lar weight (<2000 bp). The digestion of phiF61E DNA
with this enzyme gave rise to four distinct bands under
1000 bp. The same stands for the profiles obtained with
XapI: high molecular weight discriminatory bands only
above 4000 bp were detected in phiF78E DNA, whereas in
the case of phiF258E, there were more distinct bands
under this molecular weight (4000 bp). The phiF61E
digestion pattern was not very clear, probably due to over-
lapped bands. Also, divergent RFLP profiles were noticed
for SchI digestion: when comparing the two first profiles in
Fig. 6 relative to this enzyme, it can be noticed that dis-
criminatory bands of low molecular weight appeared in
the gel, only for phiF258E. phiF61E DNA did not present
any discriminatory band for this enzyme.
Discussion
APEC possess specific virulence characteristics associated
with colibacillosis. This is the primary cause of morbidity,
mortality, and rejection of carcasses at slaughter in the
poultry industry worldwide, with consequent high
economical losses (Dho-Moulin and Fairbrother 1999;
Table 1 Bacteriophages lytic score (%) by Escherichia coli O-serotype
O-serogroup phiF78E phiF258 E phiF2589E phiF61E phiF5318E
O1 0Æ00 0Æ00 0Æ00 0Æ00 0Æ00
O2 63Æ64 9Æ09 0Æ00 18Æ18 9Æ09
O5 35Æ29 5Æ88 5Æ88 47Æ06 5Æ88
O15 100Æ00 0Æ00 0Æ00 0Æ00 0Æ00
O20 0Æ00 0Æ00 0Æ00 0Æ00 0Æ00
O53 0Æ00 0Æ00 0Æ00 0Æ00 0Æ00
O78 8Æ33 30Æ73 14Æ06 23Æ96 22Æ92
O88 26Æ32 0Æ00 26Æ32 47Æ37 0Æ00
O103 100Æ00 0Æ00 0Æ00 0Æ00 0Æ00
N ⁄ T 48Æ39 16Æ13 6Æ45 19Æ35 9Æ68
Table 2 Bacteriophages sensitive strains (%)
Phage phi78E phiF258 E phiF2589E phiF61E phiF5318E
Sensitive strains (%) 35Æ14 44Æ59 23Æ65 47Æ97 33Æ11
E
D
C
B
A
0 10 20 30 40
Host lysis (%)
50
45·0
60·4
70·5
71·8
72·5
60 70 80
Figure 4 Best phage associations according to the higher percent-
age of lysis of the tested Escherichia coli strains: A ) phiF61E
(45Æ0%); B ) phiF78E + phiF61E (60Æ4%); C ) phiF78E + phiF258E +
phiF61E (70Æ5%); D ) phiF78E + phiF258E + phiF61E + phiF5318E
(71Æ8%); E ) phiF78E + phiF258E + phiF2589E + phiF61E +
phiF5318E (72Æ5%).
Isolation and characterization of coliphages A. Oliveira et al.
1924 Journal compilation ª 2009 The Society for Applied Microbiology, Journal of Applied Microbiology 106 (2009) 1919–1927
ª 2009 The Authors
Delicato et al. 2003; Ewers et al. 2004). The incidence and
severity of colibacillosis has been increasing and might
become an even greater problem in the poultry industry
(Blanco et al. 1997; Altekruse et al. 2002).
APEC can cause disease in birds of various ages and
strains. The results obtained in the present work, suggests
that the O-serotypes affected poultry, independently of
specie, strain or age. The most common typeable E. coli
O-serotype isolated from each defined group of birds was
the O78, and generically, the O2, O5 and O88 were also
found as common serotypes. This result is supported by
several in vivo E. coli pathogenicity tests performed in
poultry, in which the same O-serotypes were found to be
responsible for the most part of the colibacillosis infec-
tions (Blanco et al. 1997; Altekruse et al. 2002; Derakh-
shanfar and Ghanbarpour 2002; Raji et al. 2007; Zhao
et al. 2005; Hammoudi and Aggad 2008). Data from the
antibiograms demonstrated the high capacity of E. coli to
acquire resistance to the most frequently used antibiotics
(Fig. 3). Similar results have been reported by several
authors (Ojeniyi 1985; Van den Bogaard and Stobberingh
1999; Van den Bogaard et al. 2001).
Bacteriophages have several characteristics that make
them potentially attractive therapeutic agents against
bacterial infections. One of them is the high specificity
and effectiveness in lysing targeted pathogenic bacteria.
Due to phages high specificity, they are likely to have a
relatively narrow host range, and so, the disease agent has
to be isolated and a bacteriophage lysis test must be cus-
tomized to the specific pathogenic bacteria (Huff et al.
2004).
From another perspective, the treatment of a disease
with bacteriophage might benefit, if instead of one, a
cocktail of phages effective against the most part of the
bacteria that are known to cause the disease is used. From
this point of view, it would be useful to develop a bacte-
riophage therapeutic product based on the best phage
associations, increasing the antimicrobial range of the
product (Slopek et al. 1987; Smith et al. 1987; Carlton
1999; Sulakvelidze et al. 2001; Goodridge and Abedon
2003; Huff et al. 2004). This was the underlying reason
for testing the efficacy of several isolated E. coli phages
against a pool of the isolated APEC strains resistant to
the most common antibiotics. From the five phages iso-
lated, two revealed broad lytic spectra, being phiF61E the
most effective phage, lysing 48Æ0% of the bacterial strains.
The association of phiF78E, phiF258E and phiF61E was
effective for 70Æ5% of the strains. It is important to stress
that with only three phages, a large range of APEC strains
were covered, which is better than the most effective anti-
biotic, the ENR with 50Æ8% of efficacy (Fig. 3). A signifi-
cant increment in the lysis efficiency combinations of
four or five phages was not found beyond the efficacy
observed with three phages (71Æ8% and 72Æ5% of lysed
strains, respectively). In fact, an association of more than
three phages would be even disadvantageous, because the
economic recourses necessary to characterize and produce
different phages would be higher. Based on this assump-
tion, phiF78E, phiF258E and phiF61E were selected for
further characterization.
(a)
127 nm
135 nm 135 nm
(b) (c)
Figure 5 Bacteriophage microphotograph obtained by TEM: (a) phiF78E (magnitude: 297 000·); (b) phiF258E (magnitude 297 000·); (c) phiF61E
(magnitude: 148 500·).
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Figure 6 Agarose gel 2% stained with ethidium bromide, 5 h run at
50 V: 1 and 8 ) k DNA ⁄HindIII; 2 ) phiF78E ⁄ XapI; 3 ) phiF258E ⁄ XapI;
4 ) phiF61E ⁄ XapI; 5 ) phiF78E ⁄ BseGI; 6 ) phiF258E ⁄ BseGI; 7 )
phiF61E ⁄ BseGI; 9 ) phiF78E ⁄ SchI; 10 ) phiF258E ⁄ SchI; 11 ) phiF61E ⁄
SchI.
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The phages morphological characteristics observed by
transmission electronic microscopy (TEM) revealed that
phiF78E and phiF61E belong to Myoviridae taxonomic
family and seem to be 16–19 type phages, roughly like
T4. The same phage types have already been isolated
from sewage and characterized morphologically by
Ackermann et al. (1974), and later by Ackermann and
Nguyen (1983). Similar to phiF78E and phiF61E, the
two phages described by those authors showed contrac-
tile tails of 100 · 7 nm and 94 · 15 nm and elongated
heads with 104 · 43 or 102 · 57 nm in diameter. The
same authors described that in those phage types, heads
resembled superficially those of T-even phages and
appeared to be mostly oval. Tails of these phages were
complex and consisted generally, of a neck, a base plate
and tiny caudal fibres, similar to the phages character-
ized in this work. Those phages were so far described for
Salmonella, so, to the authors knowledge, this was the
first time that 16–19 phages are described as being
effective against E. coli strains. phiF258E seemed to be a
Siphoviridae, T1-like, already described for E. coli
(Wietzorrek et al. 2006).
One of the major concerns in the use of phages for
therapy purposes is to guarantee that the phages do not
integrate into the DNA hosts. The morphological charac-
teristics of these phages are similar to those described as
lytic; nevertheless a mitomycin C stress inducement was
performed to confirm that phage phiF78E is not temper-
ate, because resistant colonies were recovered from the
interior of the phage clear zone.
The three phages presented different structure and host
range, and therefore are distinct. This was also corrobo-
rated by their different RFLP patterns.
In short, in this work three phages belonging to the
Myoviridae and Siphoviridae families, isolated from poul-
try sewage, showed to be effective against 70Æ5% of the
148 isolated APECs, most of which were resistant to the
majority of antibiotics tested. Morphological and genetic
characterization of these phages suggests that they belong
to different phage-types. Taking together these results
suggest these three phages combined in a therapeutic
cocktail would be a more efficacious therapy over conven-
tional antibiotic therapy.
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